Analysis against human breast cancer tumor data sets implicates a clinical relevance of PDIA3 and the identified extracellular proteins to the basal subtype of breast cancer and to distant metastasis-free survival (DMFS) outcomes. This evidence concerns the gene PDIA3 and breast cancer.